RBC Capital Reaffirms Their Buy Rating on Maravai Lifesciences Holdings (MRVI)
RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company.
Business Wire8d
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
Craig-Hallum Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
Pharmabiz13h
TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology
TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology: San Diego, US Thursday, February 6, 2025, 15:00 Hrs [IST] T ...
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
Yahoo Finance9d
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Their team has made great strides in designing and developing an enzymatic DNA synthesis platform with exciting technical advantages over traditional chemical synthesis," said Trey Martin, CEO of ...